NCT02157467View on ClinicalTrials.gov

Study of Combined Oral Contraceptive Effects in Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

June 2, 2014

Primary Completion Date

August 25, 2014

Study Completion Date

August 25, 2014

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-955176

DRUG

Ortho Cyclen

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY

NCT02157467 - Study of Combined Oral Contraceptive Effects in Female Subjects | Biotech Hunter | Biotech Hunter